Research driven, human biotherapeutics company focused on rDNA products offering out-licensing of biogeneric bulk-API and finished formulations, contract research and contract manufacturing services. More
Discovery and development of new biological drugs addressing significant unmet medical needs in the areas of difficult-to-treat diseases (e.g., cancers, inflammatory/immune disease, and rare diseases) More
A privately held biotechnology company focused on the development of designer transcription factors to be used as genetic switches for turning selected genes on and off in various organisms More